iBio Inc is a biotechnology company. It is engaged in commercializing its proprietary platform technologies, iBioLaunch for vaccines and therapeutic proteins & iBioModulator for vaccine enhancement and developing select product candidates.
| Website: | www.ibioinc.com |
| Main Phone: | +1 302 355-0650 |
| Address: | 600 Madison Avenue |
| Address 2: | Suite 1601 |
| State: | NY |
| City / Town: | New York |
| Country: | USA |
| Postal Code: | 10022-1737 |
| Exchange: | AMX |
| Employees: | 9 |
| NAICS: | Pharmaceutical P |
| Last Price 0.16 | Change $ 0.002 | Change % 1.25 | Tick N/A |
| Bid N/A | Bid Size 0.00 | Ask N/A | Ask Size 0.00 |
| Open 0.17 | High 0.17 | Low 0.16 | Prev Close 0.16 |
| Last Trade | Volume 203,001 | 52 Wk Hi 0.55 | 52 Wk Low 0.14 |
| Market Cap 18.8 mi | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares 115,918,510.00 | EPS (TTM) -0.17 | PE Ratio N/A | Exchange NYSE American |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 0 | 0 |
| Number of Buys | 0 | 0 |
| Number of Sells | 0 | 0 |
| Net Activity | 0 | 0 |
| Last 10 Buys | Shares |
|---|---|
| John D. McKey | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| John D. McKey | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 3 | 3 | 3 | 3 |
| Low Target Price Estimate | 3 | 3 | 3 | 3 |
| Mean Target Price Estimate | 3 | 3 | 3 | 3 |
| Standard Deviation | 0 | 0 | 0 | 0 |
| Date of Most Recent Estimate | 02/19/13 | 02/19/13 | 02/19/13 | 02/19/13 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 10-Q | Quarterly report with a continuing view of a company's financial position | 37 | 2016-05-23 |
| NT 10-Q | Notification that form 10-Q will be submitted late | 2 | 2016-05-16 |
| SC 13D/A | Amendment to a SC 13D filing | 9 | 2016-04-11 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2016-04-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 8 | 2016-04-08 |
| DEF 14A | Official notification to shareholders of matters to be brought to a vote (Proxy) | 53 | 2016-03-11 |
| 8-K | Report of unscheduled material events or corporate changes. | 5 | 2016-03-02 |
| DEFA14A | Additional proxy soliciting materials - definitive | 5 | 2016-03-02 |
| PRE 14A | Preliminary proxy statement providing notification matters to be brought to a vote | 57 | 2016-02-29 |
| 10-Q | Quarterly report with a continuing view of a company's financial position | 146 | 2016-02-22 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 0 | 0 | 0 | 1 |
© 2018 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).
